Immunai vs Pepticom
Immunai vs Pepticom, compared side by side on 22 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Immunai is on 69/100 and Pepticom on 55/100.
Where each one leads
Immunai
- our overall score: 69/100 against 55/100
- agent readiness: 32/100 against 21/100
- domain rating: 46/100 against 24/100
- headcount: 179 against 16
- headcount growth: +13.0% against -1.8%
- funding raised: $295M against $7.6M
- LinkedIn following: 26,832 against 3,160
Pepticom
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Immunai | Pepticom |
|---|---|---|
| What it is | Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery. | AI platform for accelerating novel peptide therapeutic discovery and development. |
| Category | Healthcare, Immunology, Data, Analytics | Healthcare, Drug Discovery, Clinical Development, Peptide Drugs |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2019 | 2011 |
| Headquarters | New York, United States | Jerusalem, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Immunai | Pepticom |
|---|---|---|
| Employees | 179 | 16 |
| Headcount growthLast 12 months | +13.0% | -1.8% |
| Total funding | $295M | $7.6M |
| Latest round | Series B | Funding Round |
| Valuation | $1.0B | Not published |
| LinkedIn followers | 26,832 | 3,160 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Immunai | Pepticom |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 69/100 | 55/100 |
| Traction | 60/100 | 47/100 |
| Team | 70/100 | 70/100 |
| Search visibility | 39/100 | 33/100 |
| Quality | 78/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Immunai | Pepticom |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Tag Manager | Google Analytics 4, Google Tag Manager |
Immunai vs Pepticom: common questions
Which is better, Immunai or Pepticom?
On our 0-100 score Immunai rates higher (69/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 22 data points above: read the rows that match what you are buying for.
How do Immunai and Pepticom compare on the numbers?
Immunai leads on our overall score (69/100 against 55/100), agent readiness (32/100 against 21/100), domain rating (46/100 against 24/100), headcount (179 against 16), headcount growth (+13.0% against -1.8%), funding raised ($295M against $7.6M), LinkedIn following (26,832 against 3,160).
Read the full Immunai review and pricing or the Pepticom review and pricing. You can also browse other Immunai alternatives we track.